Vildagliptin 50mg + Metformin 500mg Tablets - Effective Diabetes Control at Best Price

जांच भेजें

Request To Call Back

Price 2 आईएनआर/ Box

मूल्य/उद्धरण प्राप्त करें

MOQ : 100 Boxes

Specification

खुराक प्रपत्र
Tablets

नमक की संरचना
Vildagliptin 50mg + Metformin 500mg

पैकेजिंग (मात्रा प्रति बॉक्स)
10x15

सामग्रियां
Vildagliptin 50mg/Metformin 500mg is a combination medicine used to treat Type 2 Diabetes Mellitus, helping control high blood sugar when diet, exercise, or single medications aren't enough, by improving insulin release (vildagliptin) and reducing glucose production/absorption (metformin) to prevent serious complications like kidney damage, blindness, heart attack, and stroke, typically taken with food to minimize stomach upset.

भौतिक रूप

खुराक
Tablets

क्वांटिटी
बॉक्सेस

Trade Information

Minimum Order Quantity
100 Boxes

डिलीवरी का समय
दिन

About

Vildagliptin 50mg/Metformin 500mg is a combination medicine used to treat Type 2 Diabetes Mellitus, helping control high blood sugar when diet, exercise, or single medications aren't enough, by improving insulin release (vildagliptin) and reducing glucose production/absorption (metformin) to prevent serious complications like kidney damage, blindness, heart attack, and stroke, typically taken with food to minimize stomach upset.

Key Uses

Blood Sugar Control: Effectively lowers elevated blood glucose (hyperglycemia) in Type 2 diabetes.

Diabetes Complication Prevention: Reduces the risk of long-term diabetes issues, including kidney disease, eye damage (retinopathy), nerve problems (neuropathy), and cardiovascular events (heart attack, stroke).

How Vildagliptin and Metformin Work Together

The blend of vildagliptin and metformin targets different mechanisms involved in glucose regulation. Vildagliptin enhances the body's ability to produce insulin and reduces glucose production, while metformin improves insulin sensitivity and decreases sugar absorption in the intestines. This dual action offers more comprehensive control of blood sugar, aiming for better long-term outcomes.

Proper Usage and Dosage

This medication comes in tablet form and should be taken as directed by your healthcare provider. Dosing schedules may vary based on individual needs but are generally taken with meals to minimize stomach upset. Consistency in timing and adherence to prescribed dosages are crucial for optimal diabetes management.

Packaging and Availability

Packaged in cartons containing 100 boxes, each box holds 10 strips of 15 tablets, ensuring adequate supply for clinical or pharmacy settings. If you are a healthcare facility, pharmacy, or medical distributor, bulk quantities are available directly from the manufacturer, supplier, or authorized trader.

FAQ's of Vildagliptin 50mg + Metformin 500mg:

Q: How does Vildagliptin 50mg + Metformin 500mg help manage Type 2 Diabetes Mellitus?

A: This tablet lowers blood glucose by combining the benefits of vildagliptin, which stimulates insulin secretion, and metformin, which reduces sugar production and absorption. As a result, it helps maintain stable blood sugar levels in patients who haven't achieved control with diet, exercise, or single-drug therapy.

Q: What are the main ingredients in this medication?

A: The active ingredients in each tablet are Vildagliptin 50mg and Metformin 500mg, formulated specifically to target high blood sugar in Type 2 Diabetes.

Q: When should I take this combination medicine?

A: Usually, Vildagliptin 50mg + Metformin 500mg is taken with meals to reduce potential stomach discomfort. Always follow the specific timing and dosage instructions provided by your healthcare provider.

Q: Where can I purchase Vildagliptin 50mg + Metformin 500mg tablets?

A: These tablets can be obtained through certified pharmaceutical suppliers, manufacturers, or authorized medical distributors in boxes containing 10 strips of 15 tablets.

Q: What is the benefit of using combination therapy over single-agent treatment?

A: Using both vildagliptin and metformin provides a broader approach to blood sugar management by impacting different biological pathways, often improving glucose control more effectively than single-agent therapy.